期 |
栏目 |
标题 |
文件 |
卷 11, 编号 1 (2019) |
Original research |
Medicamentous and non-medicamentous treatment of hip osteoarthritis in pregnant women |
(Rus)
|
卷 11, 编号 2 (2019) |
Case report |
Clinical case of an acute toxic-allergic reaction due to single intake of methotrexate |
(Rus)
|
卷 12, 编号 1 (2020) |
Original research |
The influence of tocilizumab immunogenicity markers on the effectiveness of treating rheumatoid arthritis |
(Rus)
(Eng)
|
卷 12, 编号 2 (2020) |
Original research |
新冠病毒感染的临床病程、治疗效果和疗效:初步分析 |
(Rus)
(Eng)
(简体中)
|
卷 12, 编号 4 (2020) |
Original research |
干细胞对肝硬化模型背景下肝组织功能状态的影响(实验研究) |
(Rus)
(Eng)
(简体中)
|
卷 12, 编号 3 (2020) |
Original research |
Possibilities of nailfold capillaroscopy in the differential diagnosis of immuno-inflammatory and rheumatological diseases |
(Rus)
(Eng)
|
卷 12, 编号 3 (2020) |
Original research |
无症状高尿酸血症患者的类风湿关节炎和骨关节炎病程特点 |
(Rus)
(Eng)
(简体中)
|
卷 12, 编号 4 (2020) |
Original research |
JAK激酶抑制剂用于COVID-19患者的综合治疗 |
(Rus)
(Eng)
(简体中)
|
卷 13, 编号 2 (2021) |
Reviews |
Shared pathological mechanisms of systemic lupus erythematosus and affective disorders |
|
卷 13, 编号 1 (2021) |
Original research |
细胞因子研究在COVID-19相关肺炎中的预后作用 |
|
卷 13, 编号 1 (2021) |
Original research |
最可能的与靠谱系统性红斑狼疮患者皮肤活检中免疫学标志物的概述 |
|
卷 13, 编号 2 (2021) |
Original research |
一种新型冠状病毒感染对免疫性风湿性疾病临床进程的影响 |
|
卷 13, 编号 3 (2021) |
Case report |
Formation of necrotizing vasculitis in the patient with diffuse B-cell large cell lymphoma on immune checkpoint inhibitor (PD-1) therapy |
|
卷 13, 编号 3 (2021) |
Original research |
类风湿关节炎合并高尿酸血症的临床和免疫学特点研究 |
(Rus)
(Eng)
(简体中)
|
卷 14, 编号 3 (2022) |
Original research |
Problems associated with new coronavirus infection vaccination in patients with rheumatic diseases |
(Rus)
(Eng)
|
卷 15, 编号 1 (2023) |
Reviews |
Complex treatment options of hip osteoarthritis |
|
卷 15, 编号 1 (2023) |
Original research |
Evaluation of the quality of life dynamics in comorbid patients with hip and knee joint arthroplasty |
(Rus)
|
卷 15, 编号 1 (2023) |
Original research |
Treatment of patients with knee osteoarthritis with hyaluronate sodium (Revisk) in clinical practice |
(Rus)
(Eng)
|
卷 15, 编号 2 (2023) |
Reviews |
New approaches to pathogenetic anti-inflammatory therapy of cardiovascular diseases |
|
卷 15, 编号 2 (2023) |
Original research |
Effect of thrombocytosis on cardiovascular risk in rheumatoid arthritis |
(Rus)
|
卷 14, 编号 4 (2022) |
Case report |
Disseminated seronegative echinococcosis: difficulties of diagnosis and treatment |
(Rus)
|
卷 15, 编号 3 (2023) |
Case report |
Clinical case of fulminant course of atypical hemolytic-uremic syndrome |
(Rus)
|
卷 15, 编号 4 (2023) |
Reviews |
Impact of urate-lowering therapy on the course of chronic kidney disease in patients with asymptomatic hyperuricemia: a meta-analysis of randomized controlled trials |
|
卷 15, 编号 4 (2023) |
Original research |
The influence of comorbid diseases on the profiles of signaling biomarkers (macrophage-derived chemokine, interferon-γ-induced protein 10 kD, soluble CD40 ligand, vascular endothelial growth factor) and severity in patients with COVID-19: clinical studies |
(Rus)
(Eng)
|
卷 16, 编号 2 (2024) |
Case report |
Clinical cases of vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA vasculitis) induced by COVID-19 |
|